EMED Technologies
Healthcare & Life Sci
Company overview
EMED Technologies designs and manufactures drug delivery systems for subcutaneous infusion, and was founded in 1991. Its Tetra device and SCIg60 System deliver subcutaneous immunoglobulin therapy. VersaRate is a line of flow regulators, and AccuSert and SAF-Q are specialized needle sets, both used in infusion therapy.
EMED Technologies raised $8 million in venture funding in February 2026. EMED Technologies is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- United States